Early predictors of prolonged stay in a critical care unit following aneurysmal subarachnoid hemorrhage

Neurocrit Care. 2013 Jun;18(3):291-7. doi: 10.1007/s12028-013-9815-4.

Abstract

Background: Aneurysmal subarachnoid hemorrhage (aSAH) is a neurologic emergency that typically warrants initial monitoring in a critical care setting. The aim of this study is to identify clinical and radiologic features on admission that predict a protracted critical care admission following aSAH.

Methods: Exploratory posthoc analysis was performed on the 413 patients enrolled in Clazosentan to Overcome Neurological iSChemia and Infarction OccUrring after Subarachnoid hemorrhage (CONSCIOUS-1), a prospective randomized control trial of clazosentan for the prevention of vasospasm after aSAH. The association between potential clinical and radiographic covariates, and the length of stay (LOS) in a critical care unit after aSAH was determined using a Cox proportional hazards model. Covariates with a significance level of p < 0.20, on univariate analysis, were entered into a multivariate forward conditional analysis to identify independent predictors of prolonged LOS.

Results: The mean LOS was 12.6 ± 10.6 days. On multivariate analysis, age (hazard ratio [HR] 1.01, 95 % confidence interval [CI] 1.00-1.02; p = 0.032), a history of hypertension (HR 1.30, CI 1.01-1.67; p = 0.045), and a World Federation of Neurosurgical Societies Score of IV-V on admission (HR 1.38, CI 1.05-1.81; p = 0.02) were the clinical features associated with a greater critical care LOS following aSAH. Intracerebral hemorrhage (HR 1.50, CI 1.03-2.21; p = 0.004) and increasing intraventricular clot burden (HR 1.08, CI 1.03-1.14; p = 0.037) on admission computed tomography were the radiologic features associated with prolonged LOS.

Conclusions: We have identified several early risk factors associated with a prolonged critical care stay following aSAH.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Age Factors
  • Aneurysm, Ruptured / complications
  • Aneurysm, Ruptured / epidemiology*
  • Brain / diagnostic imaging*
  • Cerebral Ventricles
  • Dioxanes / therapeutic use
  • Endothelin A Receptor Antagonists
  • Female
  • Humans
  • Hypertension / complications
  • Intensive Care Units / statistics & numerical data*
  • Intracranial Aneurysm / complications
  • Intracranial Aneurysm / epidemiology*
  • Length of Stay / statistics & numerical data*
  • Male
  • Middle Aged
  • Multivariate Analysis
  • Proportional Hazards Models
  • Prospective Studies
  • Pyridines / therapeutic use
  • Pyrimidines / therapeutic use
  • Risk Factors
  • Severity of Illness Index
  • Subarachnoid Hemorrhage / diagnostic imaging
  • Subarachnoid Hemorrhage / epidemiology*
  • Subarachnoid Hemorrhage / etiology
  • Sulfonamides / therapeutic use
  • Tetrazoles / therapeutic use
  • Tomography, X-Ray Computed
  • Vasospasm, Intracranial / etiology
  • Vasospasm, Intracranial / prevention & control

Substances

  • Dioxanes
  • Endothelin A Receptor Antagonists
  • Pyridines
  • Pyrimidines
  • Sulfonamides
  • Tetrazoles
  • clazosentan